Literature DB >> 30694937

Inflammation, Voiding and Benign Prostatic Hyperplasia Progression.

Granville L Lloyd1, William A Ricke1, Kevin T McVary2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30694937      PMCID： PMC7339115          DOI： 10.1097/JU.0000000000000049

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  5 in total

1.  Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Siobhan Sutcliffe; Robert L Grubb Iii; Elizabeth A Platz; Lawrence R Ragard; Thomas L Riley; Sally S Kazin; Richard B Hayes; Ann W Hsing; Gerald L Andriole
Journal:  BJU Int       Date:  2012-03-19       Impact factor: 5.588

2.  Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study.

Authors:  Kathleen C Torkko; R Storey Wilson; Elizabeth E Smith; John W Kusek; Adrie van Bokhoven; M Scott Lucia
Journal:  J Urol       Date:  2015-03-28       Impact factor: 7.450

Review 3.  Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials.

Authors:  Arman Kahokehr; Ryash Vather; Anthony Nixon; Andrew G Hill
Journal:  BJU Int       Date:  2013-02       Impact factor: 5.588

4.  Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey.

Authors:  Varant Kupelian; Kevin T McVary; Michael J Barry; Carol L Link; Raymond C Rosen; Lalitha Padmanabhan Aiyer; Patrick Mollon; John B McKinlay
Journal:  Urology       Date:  2009-05       Impact factor: 2.649

5.  Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.

Authors:  So Inamura; Hideaki Ito; Tomochika Shinagawa; Manami Tsutsumiuchi; Minekatsu Taga; Motohiro Kobayashi; Osamu Yokoyama
Journal:  Prostate       Date:  2018-04-02       Impact factor: 4.104
  5 in total
  3 in total

1.  Lipopolysaccharide reduces urethral smooth muscle contractility via cyclooxygenase activation.

Authors:  Fabiano B Calmasini; Eduardo C Alexandre; Mariana G Oliveira; Fábio H Silva; António G Soares; Soraia K P Costa; Edson Antunes
Journal:  J Physiol Biochem       Date:  2021-05-21       Impact factor: 4.158

Review 2.  Male Lower Urinary Tract Dysfunction: An Underrepresented Endpoint in Toxicology Research.

Authors:  Nelson T Peterson; Chad M Vezina
Journal:  Toxics       Date:  2022-02-16

3.  A multicenter retrospective study of transurethral prostate split for benign prostate hyperplasia.

Authors:  Jingchao Wei; Shigeng Zhang; Bohan Wang; Mang Ke; Sheng Liu; Zhengjia Yang; Guoyun Zhou; Jiacheng Qian; Wenhui Lv; Yi Fan; Zhan Shi; Lijun Wan; Yongliang Chen; Jinkui He; Hui Liang; Huimin Long; Shijian Wang; Hao Wang; Bing Chen; Huan Shao; Binbin Yang; Chengfang Sun; Qi Huangfu; Chuanjun Du; Ming Cai; Jiaming Wen
Journal:  Transl Androl Urol       Date:  2022-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.